Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. What is the Best Option for Elective Repair of an Abdominal Aortic Aneurysm in a Young Fit Patient?

R.M. Sandford , E. Choke , M.J. Bown , R.D. Sayers

Objective: The lower procedural risk associated with endovascular aneurysm repair (EVAR) compared with open aneurysm repair (OAR) is well known. Younger patients are likely to represent a group at low perioperative risk. The long-term durability and late complications following EVAR may have more significance when considering the optimal treatment for young patients with a longer life expectancy. This study examined perioperative and long-term outcomes of young patients undergoing aneurysm repair by either open surgical or endovascular means.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. Variation in Maximum Diameter Measurements of Descending Thoracic Aortic Aneurysms Using Unformatted Planes versus Images Corrected to Aortic Centerline

N. Rudarakanchana , C.D. Bicknell , N.J. Cheshire , N. Burfitt , A. Chapman , M. Hamady , J.T. Powell

Objective: Evaluation of variation in descending thoracic aortic aneurysm (dTAA) diameters measured on CT scans in different planes and by different observers and the potential impact on treatment decisions.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. Prevention of Type II Endoleak Using the AMPLATZER Vascular Plug Before Endovascular Aneurysm Repair

M. Burbelko , M. Kalinowski , J.T. Heverhagen , E. Piechowiak , A. Kiessling , J. Figiel , Z. Swaid , J. Geks , W. Hundt

Objective: We evaluated the feasibility of visceral artery and lumbar artery (LA) embolization using AMPLATZER vascular plug (AVP) types 4 and 2 (AVP4, AVP2) prior to endovascular aneurysm repair (EVAR) to prevent the development of a type II endoleak.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. Five-year Outcomes in Men Screened for Abdominal Aortic Aneurysm at 65 Years of Age: A Population-based Cohort Study

S. Svensjö , M. Björck , A. Wanhainen

Objective: Acquiring contemporary data on prevalence and natural history of abdominal aortic aneurysms (AAA) is essential in the effort to optimise modern screening programmes. The primary aim of this study was to determine the fate of a 65-year-old male population 5 years following an invitation to an aortic ultrasound (US) examination.

ENDOVASCULAR TODAY. Achieving Hemostasis After Tibiopedal Access

J. A. Mustapha, MD; Carolyn Fox, BSN; Larry Diaz-Sandoval, MD; and Fadi A. Saab, MD

Utilizing the tibiopedal (TP) area for alternative access during endovascular procedures has recently become more common. Achieving hemostasis at the TP junction is usually straightforward, but difficult situations may arise, depending on the exact location of the access. Our approach to access and close the TP area that has proven to be the most successful is an algorithmic method: always attempt access first with the easiest and safest vessel to enter and exit; only use the most complex and least safe access site as a last resort.

ANNALS OF VASCULAR SURGERY. Laparoscopy versus EVAR for the Treatment of Abdominal Aortic Aneurysms in the Octogenarian

Raphaël Coscas, Marc Dennery, Isabelle Javerliat, Isabelle Di Centa, Tristan Cudennec, Laurent Teillet, Olivier Goëau-Brissonniere, Marc Coggia

Background: Octogenarians are considered at high surgical risk for the treatment of abdominal aortic aneurysms (AAA). The laparoscopic aortic surgery (LAS) and the endovascular treatment (EVAR) are 2 minimum invasive techniques whose objective is to limit the operative traumatism. The objective of this study was to compare our results with short- and medium-term results with these 2 techniques in the octogenarians.

JOURNAL OF ENDOVASCULAR THERAPY. Superiority of Stent-Grafts for In-Stent Restenosis in the Superficial Femoral Artery

Marc Bosiers, MD1 Koen Deloose, MD1 Joren Callaert, MD1 Jürgen Verbist, MD2 Jeroen Hendriks, MD3 Patrick Lauwers, MD3 Herman Schroë, MD4 Wouter Lansink, MD4 Dierk Scheinert, MD5 Andrej Schmidt, MD5 Thomas Zeller, MD6 Ulrich Beschorner, MD6 Elias Noory, MD6 Giovanni Torsello, MD7 Martin Austermann, MD7 Patrick Peeters, MD2

Purpose: To evaluate the short- and midterm outcomes of the Viabahn endoprosthesis with Propaten Bioactive Surface vs. standard balloon angioplasty for treatment of in-stent restenosis in the superficial femoral artery.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.